Mie Inao

A case of non-HIV pneumocystis pneumonia in a patient with cirrhosis-associated immune dysfunction

Yoshihito Uchida, Shohei Tsuji, Mie Inao, Kayoko Sugawara et autres

jp (code pays fourni par la source)

Safety, feasibility, and acceptability of physiotherapy combined with strength training using active video games for older patients with musculoskeletal conditions

K. Takei, Shinpei Morita, Yoshinobu Watanabe, Miho Suganami et autres

jp (code pays fourni par la source)

Issue Cover

Alessio Gerussi, Damiano Verda, Davide Paolo Bernasconi, Marco Carbone et autres

Machine learning in primary biliary cholangitis: A novel approach for risk stratification

Alessio Gerussi, Damiano Verda, Davide Paolo Bernasconi, Marco Carbone et autres

it, us, jp, ca, es, fr (code pays fourni par la source)

Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis

Alessio Gerussi, Damiano Verda, Davide Paolo Bernasconi, Marco Carbone et autres

it, jp, ca, us, es, fr (code pays fourni par la source)

Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis

Yoshihito Uchida, Mie Inao, Shohei Tsuji, Hayato Uemura et autres

jp (code pays fourni par la source)

Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis

Yoshihito Uchida, Shohei Tsuji, Hayato Uemura, Jun‐ichi Kouyama et autres

jp (code pays fourni par la source)

A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitis

Minami Yagi, Kosuke Matsumoto, Atsumasa Komori, Masanori Abe et autres

jp (code pays fourni par la source)

Bezafibrate Improves GLOBE and UK‐PBC Scores and Long‐Term Outcomes in Patients With Primary Biliary Cholangitis

Akira Honda, Atsushi Tanaka, Tetsuji Kaneko, Atsumasa Komori et autres

jp (code pays fourni par la source)

Serum asunaprevir concentrations showing correlation with the extent of liver fibrosis as a factor inducing liver injuries in patients with genotype-1b hepatitis C virus receiving daclatasvir plus asunaprevir therapy

Yoshihito Uchida, Kayoko Naiki, Jun‐ichi Kouyama, Kayoko Sugawara et autres

jp (code pays fourni par la source)

Significance of NS5B Substitutions in Genotype 1b Hepatitis C Virus Evaluated by Bioinformatics Analysis

Yoshihito Uchida, Shugo Nakamura, Jun‐ichi Kouyama, Kayoko Naiki et autres

jp, us (code pays fourni par la source)

Are the Globe and UK-PBC scores also effective for predicting risk in patients treated with bezafibrate in addition to ursodeoxycholic acid?: A validation study in Japan

Akihito Tanaka, Atsumasa Komori, M. Abe, Mie Inao et autres